Our Partner
A pharmaceutical company renowned for its innovation in the discovery and development of novel first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other major diseases.
74
Total Hires
100%
of hires had oncology experience
100%
on-time fill rate
The Challenge
Our partner needed to build their first U.S. commercial infrastructure and sales force for the anticipated launch of a first-in-class oral medication to treat patients with multiple myeloma. With Orphan Drug and Fast Track designations granted by the FDA, our partner knew they needed an experienced recruiting partner to help build their first sales force. The task was compounded by a tight timeline and highly specific experience requirements.
Our Solution
Our client initially engaged the PrincetonOne team to support several executive-level commercial searches. Leveraging our deep knowledge and connections in the Pharmaceutical and Biotechnology industries, we successfully placed:
- 3 Vice Presidents (Market Access, Marketing, and Sales)
- 3 Senior Directors (Commercial Analytics, Sales Operations, and Market Access)
- 4 Medical Science Liaisons
- 1 Executive Director of Medical Affairs
After completing these critical placements, PrincetonOne supported the build-out of the partner’s 63-person Oncology Sales team.
Our Results
With the commercial leadership infrastructure in place, PrincetonOne managed the posting, sourcing, and screening for all 63 Hematology Oncology Specialist (HOS) roles. Key outcomes included:
- All 63 HOS positions were filled by the targeted start date.
- 100% of hires possessed Oncology experience, ensuring alignment with the client’s high standards.
Through rigorous candidate screening, phone assessments, and high-touch communication with the client’s team, PrincetonOne surpassed all performance objectives. This strategic partnership enabled our client to meet their aggressive timeline and establish a robust commercial infrastructure.
